Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally. Although several rapid commercial serological assays have been developed, little is known about their performance and accuracy in detecting SARS...

Full description

Bibliographic Details
Main Authors: Anwar M. Hashem, Rowa Y. Alhabbab, Abdullah Algaissi, Mohamed A. Alfaleh, Sharif Hala, Turki S. Abujamel, M-Zaki ElAssouli, Afrah A. AL-Somali, Fadwa S. Alofi, Asim A. Khogeer, Almohanad A. Alkayyal, Ahmad Bakur Mahmoud, Naif A. M. Almontashiri, Arnab Pain
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Pathogens
Subjects:
SARS-CoV-2
COVID-19
rapid assay
antibodies
serology
Online Access:https://www.mdpi.com/2076-0817/9/12/1067

Internet

https://www.mdpi.com/2076-0817/9/12/1067

Similar Items